Centessa Pharmaceuticals Company Insiders

CNTA Stock  USD 14.54  1.27  8.03%   
Centessa Pharmaceuticals' insiders are aggressively selling. The analysis of the overall insider sentiment regarding Centessa Pharmaceuticals PLC suggests that vertually all insiders are panicking. Centessa Pharmaceuticals employs about 75 people. The company is managed by 20 executives with a total tenure of roughly 175 years, averaging almost 8.0 years of service per executive, having 3.75 employees per reported executive.

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-03-20Saurabh SahaDisposed 55000 @ 16.69View
2025-03-17Iqbal J HussainDisposed 6000 @ 16.45View
2025-02-20Saurabh SahaDisposed 55000 @ 15.93View
2025-02-18Iqbal J HussainDisposed 6000 @ 16.18View
2025-02-10Karen M AndersonDisposed 429 @ 18.99View
2025-02-07Karen M AndersonDisposed 30526 @ 19.03View
2025-02-03Tia L BushDisposed 11000 @ 16.86View
2025-01-27Gregory M WeinhoffDisposed 11742 @ 16.47View
2025-01-21Saurabh SahaDisposed 55000 @ 15.77View
2025-01-15Iqbal J HussainDisposed 6000 @ 15.29View
2024-12-26Gregory M WeinhoffDisposed 10000 @ 17.04View
2024-12-20Saurabh SahaDisposed 55000 @ 17.44View
2024-12-17Tia L BushDisposed 17813 @ 18View
2024-12-16Iqbal J HussainDisposed 77705 @ 16.39View
2024-12-13Karen M AndersonDisposed 5876 @ 17.01View
2024-12-06Saurabh SahaDisposed 87496 @ 18.46View
2024-11-25Gregory M WeinhoffDisposed 10000 @ 17.66View
Monitoring Centessa Pharmaceuticals' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centessa Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Centessa Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.2047) % which means that it has lost $0.2047 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4252) %, meaning that it created substantial loss on money invested by shareholders. Centessa Pharmaceuticals' management efficiency ratios could be used to measure how well Centessa Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of March 26, 2025, Return On Tangible Assets is expected to decline to -0.43. In addition to that, Return On Capital Employed is expected to decline to -0.41. At present, Centessa Pharmaceuticals' Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 6.5 M, whereas Total Assets are forecasted to decline to about 374.4 M.
As of March 26, 2025, Common Stock Shares Outstanding is expected to decline to about 111.3 M. In addition to that, Net Loss is expected to decline to about (204.3 M)

Centessa Pharmaceuticals Workforce Comparison

Centessa Pharmaceuticals PLC is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,018. Centessa Pharmaceuticals holds roughly 75.0 in number of employees claiming about 2.49% of equities under Health Care industry.

Centessa Pharmaceuticals Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Centessa Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Centessa Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Centessa Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-03-01
0.4483
13
29
 2,222,455 
 417,393 
2024-12-01
0.3235
11
34
 185,313 
 701,013 
2024-09-01
0.2105
4
19
 830,000 
 688,948 
2024-06-01
1.2
6
5
 288,000 
 72,329 
2024-03-01
0.9412
16
17
 1,803,500 
 243,196 
2023-09-01
0.2222
2
9
 37,484 
 152,031 
2023-06-01
0.5
7
14
 336,000 
 279,137 
2023-03-01
1.6364
18
11
 1,821,600 
 82,886 
2022-12-01
0.0526
1
19
 300,000 
 134,912 
2022-09-01
0.5263
10
19
 2,111,000 
 130,687 
2022-06-01
4.5
9
2
 676,000 
 29,422 
2021-12-01
12.5
25
2
 613,000 
 150,000 
2021-06-01
1.2692
33
26
 16,193,762 
 9,703,395 

Centessa Pharmaceuticals Notable Stakeholders

A Centessa Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Centessa Pharmaceuticals often face trade-offs trying to please all of them. Centessa Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Centessa Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mario AccardiPresident ProgramProfile
MD MBAPrincipal CFOProfile
John CPACFO OfficerProfile
Tia BushChief OfficerProfile
Ellie MDSenior OncologyProfile
MD MScEx DevelProfile
April DovholukSenior OperationsProfile
JD EsqSenior CommunicationsProfile
Charlene StoudtSenior OperationsProfile
MBA MDPrincipal CFOProfile
David ChaoChief OfficerProfile
Thomas TemplemanChief OfficerProfile
Joshua MBASr DevelProfile
David GraingerChief OfficerProfile
Saurabh MDCEO DirectorProfile
Patrick MDSenior MedicinesProfile
Iqbal LLBChief CounselProfile
Harris RotmanSenior AffairsProfile
Karen AndersonChief OfficerProfile
MSc MDExecutive DevelopmentProfile

About Centessa Pharmaceuticals Management Performance

The success or failure of an entity such as Centessa Pharmaceuticals often depends on how effective the management is. Centessa Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Centessa management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Centessa management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.41)(0.43)
Return On Capital Employed(0.39)(0.41)
Return On Assets(0.41)(0.43)
Return On Equity(0.59)(0.62)
Please note, the presentation of Centessa Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Centessa Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Centessa Pharmaceuticals' management manipulating its earnings.

Centessa Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Centessa Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Centessa Pharmaceuticals within its industry.

Centessa Pharmaceuticals Manpower Efficiency

Return on Centessa Pharmaceuticals Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee3.1M
Net Loss Per Executive11.8M
Working Capital Per Employee6.4M
Working Capital Per Executive23.9M

Complementary Tools for Centessa Stock analysis

When running Centessa Pharmaceuticals' price analysis, check to measure Centessa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centessa Pharmaceuticals is operating at the current time. Most of Centessa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Centessa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Centessa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Centessa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments